Superworth

OptimizeRx price to book ratio OPRX

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
1.3×
10-year median
3.4×
Against its 10-year history
16th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.6× to 20.1×
Peer median
1.2×

OptimizeRx's price to book ratio is 1.3× as of Oct 23, 2026.

That is below its ten-year median of 3.4×, lower than on 84% of days in the last ten years.

Over that time it ranged from 0.6× in Nov 2024 to 20.1× in Feb 2021.

The median for 10 credit services stocks of a similar size is 1.2×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.3×0.7×2.0×
20251.9×0.7×3.4×
20240.8×0.6×2.5×
20232.2×1.0×2.5×
20222.2×1.8×7.5×
20218.7×6.3×20.1×
202010.1×2.3×10.2×
20193.5×3.1×10.3×
20186.9×6.2×15.3×
20177.6×2.6×7.6×
20163.0×2.9×4.3×
20153.8×3.8×6.8×
20145.0×4.1×20.1×
201311.8×6.9×20.3×
201210.7×5.2×18.9×
20116.6×6.6×14.8×

Against its peers

Companies in Financial - Credit Services nearest OptimizeRx's size, closest first, today.

CompanyPrice to book ratio
OPRXOptimizeRx1.3×
DHXDHI2.1×
CPSSConsumer Portfolio Services0.7×
SNFCASecurity National Financial0.6×
IMXIInternational Money Express1.7×
MACIMelar Acquisition Corp. I/Caymann/m
POWWOutdoor1.2×
IRHOIron Horse Acquisition IIn/m
RMRegional Management0.8×
LSAKLesaka Technologies1.7×
RMNIRimini Streetn/m
Peer median1.2×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on OptimizeRx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.